Thoughts and prayers to you and your family, BluMarlin.
I witnessed a lot of posts on Thursday March 30th that were "soft bashing" that along with the sudden dump in price to 58 cents and then large volume - well, it all was indicating that "someone" wanted in. There was a concerted effort that day, early, to create some panic selling. It was all very suspect. I just watched from the side and held my shares tight. As I have said before, I look at the market cap valuation, not the selling price. I see a market cap that is severely undervalued by 100 or 200 percent right now given the current milestones of the company - other posters are worried about 10 cents, I am saying this is worth $120M right now or up to three times current pps.
Now, Sheff bought in again, that is totally fine, actually is it awesome. He has been in TPIV three times now and along the way has provided some really good due diligence. Between Sheff, Jbem, this Ihub board, there is CONCRETE due diligence showing the value of the company long term.
A cure for cancer will never happen, there are many forms and it changes. A therapeutic treatment "cure", however, is going to be obtained where by tumors are eradicated (we are there now, but with harsh chemo). The problem now is that tumors can be eradicated, but they come back and often spread throughout the body. This is where Immunology comes in.
TPIV's immunology is the future of cancer treatment to keep the body fighting off the cancer after the eradication of the tumor(s).
Immunology and small molecule deliver of chemo are the two leading futures right now. TPIV is in the right place at the right time with the right stuff - no question in my mind that this company will be "limelight" material soon enough. I still maintain it will be acquired within the year. All the best.